Tech Company Inital Public Offerings
Bioventus IPO
On 2/16/2021, Bioventus became a public company.
Transaction Overview
Company Name
Announced On
2/16/2021
Transaction Type
IPO
Amount
$104,000,000
Proceeds Purpose
Among other things, the company will use its IPO proceeds to settle certain obligations and to pursue future potential acquisition opportunities.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
4721 Emperor Blvd. 100
Durham, NC 27703
USA
Durham, NC 27703
USA
Phone
Website
Email Address
Overview
Our mission is to partner with the health care community to help people resume and enjoy active lives. To this end, we develop and/or market clinically proven and cost-effective orthobiologic solutions for bone fusion and osteoarthritis that are backed by clinical data.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anthony Bihl
Chief Financial Officer
Greg Anglum
Chief Scientific Officer
Alessandra Pavesio
VP - Bus. Development
Jeffrey Welch
VP - General Counsel
Anthony D'Adamio
VP - Human Resources
Leigh Stradford
VP - Operations
Anthony James
Browse more venture capital transactions:
Prev: 2/15/2021: Q'Apel Medical venture capital transaction
Next: 2/17/2021: talkshoplive venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs